← FDA Drug Approvals (Drugs@FDA)

IRBESARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2012-09-27

Drug application

FDA Application #
ANDA079213
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRBESARTAN
Generic name
Irbesartan
Active ingredients
IRBESARTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ZYDUS PHARMS USA INC
First approval
2012-09-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown